Trials / Completed
CompletedNCT03751644
Peripherical Neuromuscular Electrical Stimulation in Systemic Autoimmune Myopathies
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 6 (actual)
- Sponsor
- University of Sao Paulo · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
Systemic autoimmune myopathies are a heterogeneous group of rheumatic diseases with progressive skeletal muscle weakness. The relevance of the peripherical neuromuscular electrical stimulation has never applied in the patients with systemic autoimmune myopathies. Therefore, the main objective of the present prospective, randomized, investigator-blind, placebo-controlled study is to evaluate the safety and efficacy of the application of an acute peripherical neuromuscular electrical stimulation session in patients with systemic autoimmune myopathies.
Detailed description
Systemic autoimmune myopathies are a heterogeneous group of rheumatic diseases that primarily affect the skeletal muscles. Despite these advances, this group of diseases still continues to be associated with high morbidity and functional disability, mainly due to the proximal muscular weakness of the scapular and pelvic girdles that may prevent the total recovery of these patients. On the other hand, the importance of the peripherical neuromuscular electrical stimulation has never applied in the patients with systemic autoimmune myopathies. Therefore, the main objective of the present prospective, randomized, investigator-blind, placebo-controlled study is to evaluate the safety and efficacy of the application of an acute peripherical neuromuscular electrical stimulation session in patients with systemic autoimmune myopathies.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Electrical stimulation | Patients with systemic autoimmune myopathies will receive peripheral electrical stimulation in thigh muscles |
Timeline
- Start date
- 2018-11-01
- Primary completion
- 2021-04-29
- Completion
- 2021-04-29
- First posted
- 2018-11-23
- Last updated
- 2021-04-30
Locations
1 site across 1 country: Brazil
Source: ClinicalTrials.gov record NCT03751644. Inclusion in this directory is not an endorsement.